Matthew Coffey - Net Worth and Insider Trading
Matthew Coffey Net Worth
The estimated net worth of Matthew Coffey is at least $74,281 dollars as of 2024-11-13. Matthew Coffey is the Director, Senior Officer of Oncolytics Biotech Inc and owns about 47,923 shares of Oncolytics Biotech Inc (TSX:ONC) stock worth over $74,281. Details can be seen in Matthew Coffey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Coffey has not made any transactions after 2019-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Coffey
Matthew Coffey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Coffey owns 1 companies in total, including Oncolytics Biotech Inc (TSX:ONC) .
Click here to see the complete history of Matthew Coffey’s form 4 insider trades.
Insider Ownership Summary of Matthew Coffey
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:ONC | Oncolytics Biotech Inc | 2019-10-02 | Director & Senior Officer |
Matthew Coffey Latest Holdings Summary
Matthew Coffey currently owns a total of 1 stock. Matthew Coffey owns 47,923 shares of Oncolytics Biotech Inc (TSX:ONC) as of October 2, 2019, with a value of $74,281.
Latest Holdings of Matthew Coffey
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:ONC | Oncolytics Biotech Inc | 2019-10-02 | 47,923 | 1.55 | 74,281 |
Holding Weightings of Matthew Coffey
Matthew Coffey Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Coffey has made a total of 0 transactions in Oncolytics Biotech Inc (TSX:ONC) over the past 5 years. The most-recent trade in Oncolytics Biotech Inc is the acquisition of 10,000 shares on October 2, 2019, which cost Matthew Coffey around $5,839.
Insider Trading History of Matthew Coffey
- 1
Matthew Coffey Trading Performance
GuruFocus tracks the stock performance after each of Matthew Coffey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Coffey is 395.35%. GuruFocus also compares Matthew Coffey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Coffey within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Coffey's insider trading performs compared to the benchmark.
Performance of Matthew Coffey
Matthew Coffey Ownership Network
Ownership Network List of Matthew Coffey
Ownership Network Relation of Matthew Coffey
Matthew Coffey Owned Company Details
What does Oncolytics Biotech Inc do?
Who are the key executives at Oncolytics Biotech Inc?
Matthew Coffey is the Director & Senior Officer of Oncolytics Biotech Inc. Other key executives at Oncolytics Biotech Inc include and Senior Officer Kirk Look .
Oncolytics Biotech Inc (TSX:ONC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncolytics Biotech Inc (TSX:ONC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncolytics Biotech Inc (TSX:ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncolytics Biotech Inc (TSX:ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncolytics Biotech Inc Insider Transactions
Matthew Coffey Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Coffey. Currently GuruFocus does not have mailing address information for Matthew Coffey.